Objective-To study the value of intravenous disopyramide as part of an invasive electrophysiological study in predicting impending high degree atrioventricular block in patients with bifascicular block. Design-An invasive electrophysiological study was performed in the basal state and after the infusion of disopyramide (2 mg/kg body weight). The progression to high degree atrioventricular block was assessed by bradycardia-detecting pacemakers or repeated 12-lead electrocardiogram recordings, or both. Patients-73 patients with bifascicular block were included, of whom 25 had a history of unexplained syncope. The remaining 48 patients had no arrhythmia related symptoms and were included as controls. All patients had an ejection fraction of > 35%. Results-After a mean follow up of 23 months, seven patients in the syncope group and three in the non-syncope group had a documented high degree atrioventricular block or pacemaker-detected bradycardia of < 30 beatsimin for > 6 s. The sensitivity of the disopyramide test was 71% and the specificity 98%. The corresponding figures for an abnormal electrophysiological study in the basal state were 14% and 91%, respectively. Conclusions-The sensitivity of an invasive electrophysiological study in patients with bifascicular block and syncope can be markedly increased by the use of intravenous disopyramide. A positive test is a highly specific finding and warrants pacemaker implantation. (Br Heart J 1995;74:650-655) Keywords: disopyramide stress test, atrioventricular block, bifascicular block, electrophysiological study Bifascicular block, defined as left bundle branch block or right bundle branch block with left anterior or posterior fascicular block, has a prevalence of between 1% and 1-5% in an adult population.'-3 Up to 25% of patients with bifascicular block have a history of syncope3 and the management of these patients is a common clinical problem. The overall yearly incidence of progression to high degree atrioventricular block is only 1-4%3-5 and the strategy of pacemaker implantation in all symptomatic patients can thus be questioned. No non-invasive test has been found to be useful in predicting subsequent high degree atrioventricular block, and an invasive electrophysiological study is often of limited value.47 Findings with a high specificity, such as an HV interval of > 100 ms and a His-Purkinje block during atrial pacing, are rare and hence have a low sensitivity.5 8
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(Br Heart J 1995;74:650-655) Keywords : disopyramide stress test, atrioventricular block, bifascicular block, electrophysiological study Bifascicular block, defined as left bundle branch block or right bundle branch block with left anterior or posterior fascicular block, has a prevalence of between 1% and 1-5% in an adult population.'-3 Up to 25% of patients with bifascicular block have a history of syncope3 and the management of these patients is a common clinical problem. The overall yearly incidence of progression to high degree atrioventricular block is only 1-4%3-5 and the strategy of pacemaker implantation in all symptomatic patients can thus be questioned. No non-invasive test has been found to be useful in predicting subsequent high degree atrioventricular block, and an invasive electrophysiological study is often of limited value.47 Findings with a high specificity, such as an HV interval of > 100 ms and a His-Purkinje block during atrial pacing, are rare and hence have a low sensitivity. 5 8 In order to increase the sensitivity of an electrophysiological study, a pharmacological stress test of the His-Purkinje system has been proposed, and ajmaline,9 10 procainamide,"-13 and disopyramide'4 '5 have been used for this purpose. The clinical value of these tests has, however, not been well defined, primarily because of the lack of appropriate controls and the lack of sensitive tools for detecting intermittent high degree atrioventricular block.
The aim of this study was to evaluate prospectively the value of intravenous disopyramide as part of an invasive electrophysiological study in predicting impending high degree atrioventricular block in patients with bifascicular block.
Methods

PATIENTS
Between October 1991 and November 1993, 73 patients with bifascicular block were studied prospectively. Twenty five had a history of syncope, and 48 had not. Most of the patients in the syncope group were recruited from four casualty departments. Patients in whom significant brady-or tachyarrhythmias were found on a 24 h telemetry recording were excluded.
The control group was identified by using a computerised storage unit for 12-lead electrocardiograms. Patients under the age of 85 years with a bifascicular block were screened and asked to participate in the study. Twelve of these patients were found to have a history of syncopal attacks and were included in the syncope group. The remaining subjects had no history of syncope or presyncope, palpitations, or dizzy spells and formed the control group.
Before the electrophysiological study, a careful history was taken from all patients and they received a physical examination, a chest x ray, and an echo Doppler examination, including assessment of the left ventricular ejection fraction, according to Simpson. '6 Because of the negative inotropic effect of disopyramide, patients with an ejection fraction of < 35% or uncompensated heart failure were not included. (20) CHF (%) 5 (20) 7 (14) Cardiomyopathy (%) 0 (0) 1 (2) Hypertension (%) 5 (20) 12 (24) VOC (%) 0 (0) 2 (4) Atrial fibrillation (%) 1 (4) 4 (8) No structural heart disease (%) '9 Sensitivity was defined in the syncope group as the number of patients with a positive test and high degree atrioventricular block or pacemaker detected bradycardia during follow up, or both, (true positives) divided by the total number of patients with high degree atrioventricular block or pacemaker detected bradycardia, or both. The specificity was defined in the non-syncope group as the number of patients with a negative test and no documented high degree atrioventricular block or pacemaker detected bradycardia during follow up (true negatives) divided by the total number of patients with no documented high degree atrioventricular block or pacemaker detected bradycardia.'0 The Kaplan Meier method2' was used for comparing patients with positive and negative disopyramide tests regarding the development of high degree atrioventricular block or pacemaker detected bradycardia during follow up. All analyses were performed using the statistical package of JMP®, version 3 0 (SAS Institute). A P value < 0-05 was considered statistically significant.
ETHICS
The procedure of the electrophysiological study was explained in detail to each patient before inclusion and verbal consent was obtained, in accordance with the guidelines of the ethics committee of the Karolinska Hospital, which had approved the study.
Results
STUDY GROUPS
The two study groups were well matched with regard to demographic and clinical characteristics, ejection fraction, and type of bifascicular block ( Since invasive electrophysiological testing presently is indicated only in symptomatic patients with bifascicular block,22 we assessed the sensitivity by using the syncope group. It is, however, important to note that all three patients in the non-syncope group who had high degree atrioventricular block or bradycardia during follow up had a positive disopyramide test.
SPECIFICITY
The specificity of the disopyramide test was previously unknown. By including a large control group of asymptomatic individuals who had similar clinical characteristics to those of the group of symptomatic patients, this study was specifically designed to address this issue. In order to define the specificity of a diagnostic and prognostic test, it is crucial to have a population truly devoid of the disorder studied. We defined this as patients in the non-syncope group who had no documented high degree atrioventricular block or bradycardia during follow up. It can be argued that this definition is too strict and that syncope patients without documented bradycardia during follow up should also be added to the asymptomatic population. This would, however, only marginally affect the specificity, with a decrease from 98% to 94%.
PREVIOUS STUDIES ON ELECTROPHYSIOLOGICAL FINDINGS IN THE BASAL STATE
Like previous reports,46 this study shows that an electrophysiological study in a patient with bifascicular block is often inconclusive when performed in the basal state. Previous studies have shown conflicting results on the value of a prolonged HV interval in predicting progression to high degree atrioventricular block.467 Scheinman et aP found that patients with an HV interval of more than 70 ms had a more than doubled risk. In our study, this finding had a high specificity but a low sensitivity. In accordance with previous studies, we found that His-Purkinje block during atrial pacing is a rare finding. 8 12 23 Programmed The sensitivity was 44% in predicting subsequent high degree atrioventricular block in one study,9 but the progression rate was too low to allow assessment of the predictive value in the others.
The first study of the use of disopyramide as a pharmacological stress test was a retrospective study, generating the criteria for a positive test used in the present study.14 An extension of that study proved the usefulness of the bradycardia-detecting pacemaker.'5 Although the design and study populations differ substantially, the present prospective study confirms the high predictive value of the test.
There is no consensus in published reports about the evaluation and treatment of patients with bifascicular block and a history of unexplained syncope. In some textbooks the authors advocate permanent pacemaker treatment in all symptomatic patients,'4 whereas others recommend an invasive electrophysiological study unless a significant bradycardia is documented.'5'7 The first policy is supported by the fact that the risk of symptomatic bradycardia is eliminated without the cost of an invasive electrophysiological study. Several arguments, however, favour the second strategy. The annual progression rate to high degree atrioventricular block is low at 1-4%, implying that a large number of patients will not need their pacemaker. Although modem pacemaker treatment is safe, it is certainly not free from complications and the patients are committed to lifelong treatment. Moreover, pacemaker treatment has not been shown to influence the mortality5 6 and, by not performing an electrophysiological study, other arrhythmias, such as ventricular tachycardia, might go undiagnosed. In the present study, the policy of pacing only patients with a positive disopyramide test would have resulted in pacemaker treatment in eight patients, in contrast to the 25 patients who would have received a pacemaker if the first policy had been applied. However, two patients with pacemakerdetected bradycardia but not documented high degree atrioventricular block would have been left untreated.
Thus it is our belief that permanent pacemaker treatment cannot be recommended to all symptomatic patients with bifasciciular block on the basis of this study.
LIMITATIONS
Since we used a bradycardia-detecting pacemaker with only a ventricular lead, we could not differentiate between bradycardia due to intermittent atrioventricular block and atrial bradycardia. Although previous studies have shown a good relationship between pacemaker-detected bradycardia and subsequent development of high degree atrioventricular block,'5 17 a more recent study using dual chamber bradycardia-detecting pacemakers indicates that sinus bradycardia is also a common phenomenon in patients with suspected atrioventricular block. 28 In order to minimise the risk for the asymptomatic volunteers, we applied strict exclusion criteria regarding impaired left ventricular function. This may raise doubts about the general applicability of the test to a symptomatic population. The majority of exclusions were because of an ejection fraction of < 35%. On the basis of previous experience of symptomatic patients,'4 1 ' this is probably too strict a criterion.
CONCLUSIONS
An invasive electrophysiological study in the basal state is often inconclusive in patients with bifascicular block and syncope. An HV interval of more than 70 ms and His-Purkinje block during atrial pacing are findings with a high specificity but low sensitivity for the prediction of impending high degree atrioventricular block. In patients without any of these findings, a pharmacological stress test should be considered. The disopyramide test has a high predictive value and a high specificity. Because it has a negative inotropic effect, the test should not be performed in patients with poor left ventricular function.
